Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy

Psoriasis is a chronic skin disease that affects millions of people throughout the world. Even though cutaneous signs and symptoms are the most common clinical manifestations, the nails can be involved in up to 50% of cases, and their involvement remains an important yet often overlooked aspect of t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Academy of Dermatology 2007-07, Vol.57 (1), p.1-27
Hauptverfasser: Jiaravuthisan, Michael M., BSc, BA, MD, Sasseville, Denis, MD, FRCP(C), Vender, Ronald B., MD, FRCP(C), Murphy, Francis, MD, FRCP(C), Muhn, Channy Y., MD, FRCP(C)
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 27
container_issue 1
container_start_page 1
container_title Journal of the American Academy of Dermatology
container_volume 57
creator Jiaravuthisan, Michael M., BSc, BA, MD
Sasseville, Denis, MD, FRCP(C)
Vender, Ronald B., MD, FRCP(C)
Murphy, Francis, MD, FRCP(C)
Muhn, Channy Y., MD, FRCP(C)
description Psoriasis is a chronic skin disease that affects millions of people throughout the world. Even though cutaneous signs and symptoms are the most common clinical manifestations, the nails can be involved in up to 50% of cases, and their involvement remains an important yet often overlooked aspect of the disease. There is a broad spectrum of nail dystrophies associated with psoriasis, ranging from the common pitting and loosening of the nail plate to the less frequent discoloration and splinter hemorrhages seen in the nail bed. This article discusses the normal anatomy and embryology of the nail unit as well as the current understanding of the pathogenesis of the disease. It also provides an extensive review of the existing literature with respect to psoriatic nail therapy. Although there have been many recent advances in the treatment of the cutaneous form of the disease—most notably in the field of immunotherapies—the options for nail psoriasis are far more limited. While a number of treatment alternatives currently exist for nail disease, the general paucity of clear evidence regarding these choices often makes it difficult to select the most efficient, safe, and optimal treatment for the patient. Even though the current literature has shown some support for the use of topical, intralesional, radiation, systemic, and combination therapies for nail psoriasis, the available studies lack sufficient power to extrapolate a standardized therapeutic regimen. Therefore, until better-documented evidence validating the treatment options emerges within the literature, clinicians and patients are left with a vague and relatively unproven approach to psoriatic nail disease.
doi_str_mv 10.1016/j.jaad.2005.07.073
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70631416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0190962205032287</els_id><sourcerecordid>70631416</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-e6bbd1218613763cbbd21afbf207efdd98c3c60be62ed405484ce4c9421e9df93</originalsourceid><addsrcrecordid>eNp9kt2K1DAUx4so7uzqC3ghvdGr7XiStEkjIiyLX7CgoF6HNDl1UztJN2ld5m18Fp_MlJllwQvhQD74nT_hl1MUzwhsCRD-atgOWtstBWi2IHKxB8WGgBQVF614WGyASKgkp_SkOE1pAABZM_G4OCGiEZQKsSnGLylEp5NLZejL-RpLr934urzweg67_Xk56fk6jOFH3prReWf0-Of3FDGhn_Xsgj8vtbelLiP-cnh7lzK6GaOel4hl8OtN1NP-SfGo12PCp8f1rPj-_t23y4_V1ecPny4vrirTMJgr5F1nCSUtJ0xwZvKJEt13PQWBvbWyNcxw6JBTtDU0dVsbrI2sKUFpe8nOipeH3CmGmwXTrHYuGRxH7TEsSQngjNSEZ5AeQBNDShF7NUW303GvCKjVsRrU6litjhWIXCw3PT-mL90O7X3LUWoGXhwBnbKuPmpvXLrnWgmCSsjcmwOH2UWWF1UyDr1B6yKaWdng_v-Ot_-0333QT9xjGsISfbasiEpUgfq6TsM6DNAAo7QV7C8mrLEP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70631416</pqid></control><display><type>article</type><title>Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Jiaravuthisan, Michael M., BSc, BA, MD ; Sasseville, Denis, MD, FRCP(C) ; Vender, Ronald B., MD, FRCP(C) ; Murphy, Francis, MD, FRCP(C) ; Muhn, Channy Y., MD, FRCP(C)</creator><creatorcontrib>Jiaravuthisan, Michael M., BSc, BA, MD ; Sasseville, Denis, MD, FRCP(C) ; Vender, Ronald B., MD, FRCP(C) ; Murphy, Francis, MD, FRCP(C) ; Muhn, Channy Y., MD, FRCP(C)</creatorcontrib><description>Psoriasis is a chronic skin disease that affects millions of people throughout the world. Even though cutaneous signs and symptoms are the most common clinical manifestations, the nails can be involved in up to 50% of cases, and their involvement remains an important yet often overlooked aspect of the disease. There is a broad spectrum of nail dystrophies associated with psoriasis, ranging from the common pitting and loosening of the nail plate to the less frequent discoloration and splinter hemorrhages seen in the nail bed. This article discusses the normal anatomy and embryology of the nail unit as well as the current understanding of the pathogenesis of the disease. It also provides an extensive review of the existing literature with respect to psoriatic nail therapy. Although there have been many recent advances in the treatment of the cutaneous form of the disease—most notably in the field of immunotherapies—the options for nail psoriasis are far more limited. While a number of treatment alternatives currently exist for nail disease, the general paucity of clear evidence regarding these choices often makes it difficult to select the most efficient, safe, and optimal treatment for the patient. Even though the current literature has shown some support for the use of topical, intralesional, radiation, systemic, and combination therapies for nail psoriasis, the available studies lack sufficient power to extrapolate a standardized therapeutic regimen. Therefore, until better-documented evidence validating the treatment options emerges within the literature, clinicians and patients are left with a vague and relatively unproven approach to psoriatic nail disease.</description><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2005.07.073</identifier><identifier>PMID: 17572277</identifier><identifier>CODEN: JAADDB</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Administration, Topical ; Adrenal Cortex Hormones - administration &amp; dosage ; Anthralin - therapeutic use ; Biological and medical sciences ; Clinical Trials as Topic ; Cyclosporine - therapeutic use ; Dermatology ; Fluorouracil - therapeutic use ; Humans ; Injections, Intralesional ; Medical sciences ; Nail Diseases - diagnosis ; Nail Diseases - pathology ; Nail Diseases - radiotherapy ; Nail Diseases - therapy ; Nails - anatomy &amp; histology ; Nails - embryology ; Nails - physiology ; Nicotinic Acids - therapeutic use ; Photochemotherapy ; Phototherapy ; Psoriasis - diagnosis ; Psoriasis - immunology ; Psoriasis - pathology ; Psoriasis - radiotherapy ; Psoriasis - therapy ; Psoriasis. Parapsoriasis. Lichen</subject><ispartof>Journal of the American Academy of Dermatology, 2007-07, Vol.57 (1), p.1-27</ispartof><rights>American Academy of Dermatology, Inc.</rights><rights>2007 American Academy of Dermatology, Inc.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-e6bbd1218613763cbbd21afbf207efdd98c3c60be62ed405484ce4c9421e9df93</citedby><cites>FETCH-LOGICAL-c530t-e6bbd1218613763cbbd21afbf207efdd98c3c60be62ed405484ce4c9421e9df93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962205032287$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18907290$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17572277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jiaravuthisan, Michael M., BSc, BA, MD</creatorcontrib><creatorcontrib>Sasseville, Denis, MD, FRCP(C)</creatorcontrib><creatorcontrib>Vender, Ronald B., MD, FRCP(C)</creatorcontrib><creatorcontrib>Murphy, Francis, MD, FRCP(C)</creatorcontrib><creatorcontrib>Muhn, Channy Y., MD, FRCP(C)</creatorcontrib><title>Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>Psoriasis is a chronic skin disease that affects millions of people throughout the world. Even though cutaneous signs and symptoms are the most common clinical manifestations, the nails can be involved in up to 50% of cases, and their involvement remains an important yet often overlooked aspect of the disease. There is a broad spectrum of nail dystrophies associated with psoriasis, ranging from the common pitting and loosening of the nail plate to the less frequent discoloration and splinter hemorrhages seen in the nail bed. This article discusses the normal anatomy and embryology of the nail unit as well as the current understanding of the pathogenesis of the disease. It also provides an extensive review of the existing literature with respect to psoriatic nail therapy. Although there have been many recent advances in the treatment of the cutaneous form of the disease—most notably in the field of immunotherapies—the options for nail psoriasis are far more limited. While a number of treatment alternatives currently exist for nail disease, the general paucity of clear evidence regarding these choices often makes it difficult to select the most efficient, safe, and optimal treatment for the patient. Even though the current literature has shown some support for the use of topical, intralesional, radiation, systemic, and combination therapies for nail psoriasis, the available studies lack sufficient power to extrapolate a standardized therapeutic regimen. Therefore, until better-documented evidence validating the treatment options emerges within the literature, clinicians and patients are left with a vague and relatively unproven approach to psoriatic nail disease.</description><subject>Administration, Topical</subject><subject>Adrenal Cortex Hormones - administration &amp; dosage</subject><subject>Anthralin - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Cyclosporine - therapeutic use</subject><subject>Dermatology</subject><subject>Fluorouracil - therapeutic use</subject><subject>Humans</subject><subject>Injections, Intralesional</subject><subject>Medical sciences</subject><subject>Nail Diseases - diagnosis</subject><subject>Nail Diseases - pathology</subject><subject>Nail Diseases - radiotherapy</subject><subject>Nail Diseases - therapy</subject><subject>Nails - anatomy &amp; histology</subject><subject>Nails - embryology</subject><subject>Nails - physiology</subject><subject>Nicotinic Acids - therapeutic use</subject><subject>Photochemotherapy</subject><subject>Phototherapy</subject><subject>Psoriasis - diagnosis</subject><subject>Psoriasis - immunology</subject><subject>Psoriasis - pathology</subject><subject>Psoriasis - radiotherapy</subject><subject>Psoriasis - therapy</subject><subject>Psoriasis. Parapsoriasis. Lichen</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kt2K1DAUx4so7uzqC3ghvdGr7XiStEkjIiyLX7CgoF6HNDl1UztJN2ld5m18Fp_MlJllwQvhQD74nT_hl1MUzwhsCRD-atgOWtstBWi2IHKxB8WGgBQVF614WGyASKgkp_SkOE1pAABZM_G4OCGiEZQKsSnGLylEp5NLZejL-RpLr934urzweg67_Xk56fk6jOFH3prReWf0-Of3FDGhn_Xsgj8vtbelLiP-cnh7lzK6GaOel4hl8OtN1NP-SfGo12PCp8f1rPj-_t23y4_V1ecPny4vrirTMJgr5F1nCSUtJ0xwZvKJEt13PQWBvbWyNcxw6JBTtDU0dVsbrI2sKUFpe8nOipeH3CmGmwXTrHYuGRxH7TEsSQngjNSEZ5AeQBNDShF7NUW303GvCKjVsRrU6litjhWIXCw3PT-mL90O7X3LUWoGXhwBnbKuPmpvXLrnWgmCSsjcmwOH2UWWF1UyDr1B6yKaWdng_v-Ot_-0333QT9xjGsISfbasiEpUgfq6TsM6DNAAo7QV7C8mrLEP</recordid><startdate>20070701</startdate><enddate>20070701</enddate><creator>Jiaravuthisan, Michael M., BSc, BA, MD</creator><creator>Sasseville, Denis, MD, FRCP(C)</creator><creator>Vender, Ronald B., MD, FRCP(C)</creator><creator>Murphy, Francis, MD, FRCP(C)</creator><creator>Muhn, Channy Y., MD, FRCP(C)</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070701</creationdate><title>Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy</title><author>Jiaravuthisan, Michael M., BSc, BA, MD ; Sasseville, Denis, MD, FRCP(C) ; Vender, Ronald B., MD, FRCP(C) ; Murphy, Francis, MD, FRCP(C) ; Muhn, Channy Y., MD, FRCP(C)</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-e6bbd1218613763cbbd21afbf207efdd98c3c60be62ed405484ce4c9421e9df93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Administration, Topical</topic><topic>Adrenal Cortex Hormones - administration &amp; dosage</topic><topic>Anthralin - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Cyclosporine - therapeutic use</topic><topic>Dermatology</topic><topic>Fluorouracil - therapeutic use</topic><topic>Humans</topic><topic>Injections, Intralesional</topic><topic>Medical sciences</topic><topic>Nail Diseases - diagnosis</topic><topic>Nail Diseases - pathology</topic><topic>Nail Diseases - radiotherapy</topic><topic>Nail Diseases - therapy</topic><topic>Nails - anatomy &amp; histology</topic><topic>Nails - embryology</topic><topic>Nails - physiology</topic><topic>Nicotinic Acids - therapeutic use</topic><topic>Photochemotherapy</topic><topic>Phototherapy</topic><topic>Psoriasis - diagnosis</topic><topic>Psoriasis - immunology</topic><topic>Psoriasis - pathology</topic><topic>Psoriasis - radiotherapy</topic><topic>Psoriasis - therapy</topic><topic>Psoriasis. Parapsoriasis. Lichen</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiaravuthisan, Michael M., BSc, BA, MD</creatorcontrib><creatorcontrib>Sasseville, Denis, MD, FRCP(C)</creatorcontrib><creatorcontrib>Vender, Ronald B., MD, FRCP(C)</creatorcontrib><creatorcontrib>Murphy, Francis, MD, FRCP(C)</creatorcontrib><creatorcontrib>Muhn, Channy Y., MD, FRCP(C)</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiaravuthisan, Michael M., BSc, BA, MD</au><au>Sasseville, Denis, MD, FRCP(C)</au><au>Vender, Ronald B., MD, FRCP(C)</au><au>Murphy, Francis, MD, FRCP(C)</au><au>Muhn, Channy Y., MD, FRCP(C)</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2007-07-01</date><risdate>2007</risdate><volume>57</volume><issue>1</issue><spage>1</spage><epage>27</epage><pages>1-27</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><coden>JAADDB</coden><abstract>Psoriasis is a chronic skin disease that affects millions of people throughout the world. Even though cutaneous signs and symptoms are the most common clinical manifestations, the nails can be involved in up to 50% of cases, and their involvement remains an important yet often overlooked aspect of the disease. There is a broad spectrum of nail dystrophies associated with psoriasis, ranging from the common pitting and loosening of the nail plate to the less frequent discoloration and splinter hemorrhages seen in the nail bed. This article discusses the normal anatomy and embryology of the nail unit as well as the current understanding of the pathogenesis of the disease. It also provides an extensive review of the existing literature with respect to psoriatic nail therapy. Although there have been many recent advances in the treatment of the cutaneous form of the disease—most notably in the field of immunotherapies—the options for nail psoriasis are far more limited. While a number of treatment alternatives currently exist for nail disease, the general paucity of clear evidence regarding these choices often makes it difficult to select the most efficient, safe, and optimal treatment for the patient. Even though the current literature has shown some support for the use of topical, intralesional, radiation, systemic, and combination therapies for nail psoriasis, the available studies lack sufficient power to extrapolate a standardized therapeutic regimen. Therefore, until better-documented evidence validating the treatment options emerges within the literature, clinicians and patients are left with a vague and relatively unproven approach to psoriatic nail disease.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>17572277</pmid><doi>10.1016/j.jaad.2005.07.073</doi><tpages>27</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0190-9622
ispartof Journal of the American Academy of Dermatology, 2007-07, Vol.57 (1), p.1-27
issn 0190-9622
1097-6787
language eng
recordid cdi_proquest_miscellaneous_70631416
source MEDLINE; Elsevier ScienceDirect Journals
subjects Administration, Topical
Adrenal Cortex Hormones - administration & dosage
Anthralin - therapeutic use
Biological and medical sciences
Clinical Trials as Topic
Cyclosporine - therapeutic use
Dermatology
Fluorouracil - therapeutic use
Humans
Injections, Intralesional
Medical sciences
Nail Diseases - diagnosis
Nail Diseases - pathology
Nail Diseases - radiotherapy
Nail Diseases - therapy
Nails - anatomy & histology
Nails - embryology
Nails - physiology
Nicotinic Acids - therapeutic use
Photochemotherapy
Phototherapy
Psoriasis - diagnosis
Psoriasis - immunology
Psoriasis - pathology
Psoriasis - radiotherapy
Psoriasis - therapy
Psoriasis. Parapsoriasis. Lichen
title Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A38%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psoriasis%20of%20the%20nail:%20Anatomy,%20pathology,%20clinical%C2%A0presentation,%20and%20a%20review%20of%20the%20literature%20on%20therapy&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Jiaravuthisan,%20Michael%20M.,%20BSc,%20BA,%20MD&rft.date=2007-07-01&rft.volume=57&rft.issue=1&rft.spage=1&rft.epage=27&rft.pages=1-27&rft.issn=0190-9622&rft.eissn=1097-6787&rft.coden=JAADDB&rft_id=info:doi/10.1016/j.jaad.2005.07.073&rft_dat=%3Cproquest_cross%3E70631416%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70631416&rft_id=info:pmid/17572277&rft_els_id=1_s2_0_S0190962205032287&rfr_iscdi=true